StockData
Kyntra Bio, Inc. logo

Kyntra Bio, Inc. (KYNB) stock

KYNBNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 5/30
$2.04−1.16 (-36.25%)

Close on Nov 17, 2026Market cap $8.26MP/E 0.0Yield –

Kyntra Bio operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Kyntra Bio's operating cash flow for the twelve months ending Jun 30, 2026 was -$38.05M. For fiscal 2025 it was -$4.77M. The highest annual figure on record is $81.60M in fiscal 2020.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$4.77M–
FY2024Dec 31, 2024-$138.00M–
FY2023Dec 31, 2023-$315.02M–
FY2022Dec 31, 2022-$145.93M–
FY2021Dec 31, 2021-$82.23M-200.8%
FY2020Dec 31, 2020$81.60M–
FY2019Dec 31, 2019-$78.71M–
FY2018Dec 31, 2018-$76.14M–
FY2017Dec 31, 2017-$66.51M-1035.7%
FY2016Dec 31, 2016$7.11M–
FY2015Dec 31, 2015-$18.57M-182.9%
FY2014Dec 31, 2014$22.41M-13.5%
FY2013Dec 31, 2013$25.92M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$3.99M-131.5%
Q1 FY2026Mar 31, 2026-$13.89M-610.7%
Q4 FY2025Dec 31, 2025-$18.33M–
Q3 FY2025Sep 30, 2025-$1.85M–
Q2 FY2025Jun 30, 2025$12.68M–
Q1 FY2025Mar 31, 2025$2.72M–
Q4 FY2024Dec 31, 2024-$30.47M–
Q3 FY2024Sep 30, 2024-$8.38M–
Q2 FY2024Jun 30, 2024-$39.87M–
Q1 FY2024Mar 31, 2024-$59.29M–
Q4 FY2023Dec 31, 2023-$18.32M–
Q3 FY2023Sep 30, 2023-$84.54M–
Q2 FY2023Jun 30, 2023-$110.57M–
Q1 FY2023Mar 31, 2023-$101.59M–
Q4 FY2022Dec 31, 2022-$52.51M–
Q3 FY2022Sep 30, 2022-$51.88M-217.2%
Q2 FY2022Jun 30, 2022-$33.06M–
Q1 FY2022Mar 31, 2022-$8.48M–
Q4 FY2021Dec 31, 2021-$54.96M–
Q3 FY2021Sep 30, 2021$44.26M–
Q2 FY2021Jun 30, 2021-$26.54M-117.7%
Q1 FY2021Mar 31, 2021-$44.98M–
Q4 FY2020Dec 31, 2020-$7.23M–
Q3 FY2020Sep 30, 2020-$1.35M–
Q2 FY2020Jun 30, 2020$149.67M–
Q1 FY2020Mar 31, 2020-$59.49M-364.6%
Q4 FY2019Dec 31, 2019-$45.05M–
Q3 FY2019Sep 30, 2019-$27.48M-433.2%
Q2 FY2019Jun 30, 2019-$28.65M–
Q1 FY2019Mar 31, 2019$22.48M–
Q4 FY2018Dec 31, 2018-$17.47M–
Q3 FY2018Sep 30, 2018$8.25M–
Q2 FY2018Jun 30, 2018-$34.96M–
Q1 FY2018Mar 31, 2018-$31.96M–
Q4 FY2017Dec 31, 2017-$1.19M–
Q3 FY2017Sep 30, 2017-$18.43M–
Q2 FY2017Jun 30, 2017-$19.76M–
Q1 FY2017Mar 31, 2017-$27.14M–
Q4 FY2016Dec 31, 2016-$18.55M–
Q3 FY2016Sep 30, 2016-$1.77M–

More Kyntra Bio figures

See a number that looks wrong?